BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12496447)

  • 21. Enhanced priming of antigen-specific CTLs in vivo by embryonic stem cell-derived dendritic cells expressing chemokine along with antigenic protein: application to antitumor vaccination.
    Matsuyoshi H; Senju S; Hirata S; Yoshitake Y; Uemura Y; Nishimura Y
    J Immunol; 2004 Jan; 172(2):776-86. PubMed ID: 14707047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Migration and activation of T cells during development of graft-versus-host disease in a mouse model.
    Wen HS; Wang JM; Zhou H; Gong SI; Gao L; Wu Y
    Transplant Proc; 2013 Mar; 45(2):713-8. PubMed ID: 23498811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmented expression of secondary lymphoid tissue chemokine and EBI1 ligand chemokine in Crohn's disease.
    Kawashima D; Oshitani N; Jinno Y; Watanabe K; Nakamura S; Higuchi K; Arakawa T
    J Clin Pathol; 2005 Oct; 58(10):1057-63. PubMed ID: 16189151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
    J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease.
    Ushiyama C; Hirano T; Miyajima H; Okumura K; Ovary Z; Hashimoto H
    J Immunol; 1995 Mar; 154(6):2687-96. PubMed ID: 7876541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function.
    Lang TJ; Nguyen P; Peach R; Gause WC; Via CS
    J Immunol; 2002 Apr; 168(8):3786-92. PubMed ID: 11937530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of donor T cells for target organ injuries in acute and chronic graft-versus-host disease.
    Kataoka Y; Iwasaki T; Kuroiwa T; Seto Y; Iwata N; Hashimoto N; Ogata A; Hamano T; Kakishita E
    Immunology; 2001 Jul; 103(3):310-8. PubMed ID: 11454060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCR7 ligands, SLC/6Ckine/Exodus2/TCA4 and CKbeta-11/MIP-3beta/ELC, are chemoattractants for CD56(+)CD16(-) NK cells and late stage lymphoid progenitors.
    Kim CH; Pelus LM; Appelbaum E; Johanson K; Anzai N; Broxmeyer HE
    Cell Immunol; 1999 May; 193(2):226-35. PubMed ID: 10222066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
    Teshima T; Hill GR; Pan L; Brinson YS; van den Brink MR; Cooke KR; Ferrara JL
    J Clin Invest; 1999 Aug; 104(3):317-25. PubMed ID: 10430613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene duplications at the chemokine locus on mouse chromosome 4: multiple strain-specific haplotypes and the deletion of secondary lymphoid-organ chemokine and EBI-1 ligand chemokine genes in the plt mutation.
    Nakano H; Gunn MD
    J Immunol; 2001 Jan; 166(1):361-9. PubMed ID: 11123313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCR7 guides migration of mesenchymal stem cell to secondary lymphoid organs: a novel approach to separate GvHD from GvL effect.
    Li H; Jiang Y; Jiang X; Guo X; Ning H; Li Y; Liao L; Yao H; Wang X; Liu Y; Zhang Y; Chen H; Mao N
    Stem Cells; 2014 Jul; 32(7):1890-903. PubMed ID: 24496849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease.
    Murai M; Yoneyama H; Harada A; Yi Z; Vestergaard C; Guo B; Suzuki K; Asakura H; Matsushima K
    J Clin Invest; 1999 Jul; 104(1):49-57. PubMed ID: 10393698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Administration of an IL-12-encoding DNA plasmid prevents the development of chronic graft-versus-host disease (GVHD).
    Okubo T; Hagiwara E; Ohno S; Tsuji T; Ihata A; Ueda A; Shirai A; Aoki I; Okuda K; Miyazaki J; Ishigatsubo Y
    J Immunol; 1999 Apr; 162(7):4013-7. PubMed ID: 10201922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease.
    Via CS; Rus V; Gately MK; Finkelman FD
    J Immunol; 1994 Nov; 153(9):4040-7. PubMed ID: 7930611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ischemia-induced neuronal expression of the microglia attracting chemokine Secondary Lymphoid-tissue Chemokine (SLC).
    Biber K; Sauter A; Brouwer N; Copray SC; Boddeke HW
    Glia; 2001 Apr; 34(2):121-33. PubMed ID: 11307161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA
    J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes.
    Saeki H; Moore AM; Brown MJ; Hwang ST
    J Immunol; 1999 Mar; 162(5):2472-5. PubMed ID: 10072485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization.
    Gunn MD; Kyuwa S; Tam C; Kakiuchi T; Matsuzawa A; Williams LT; Nakano H
    J Exp Med; 1999 Feb; 189(3):451-60. PubMed ID: 9927507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical role of interleukin-2 in the development of acute graft-versus-host disease.
    Via CS; Finkelman FD
    Int Immunol; 1993 Jun; 5(6):565-72. PubMed ID: 8102248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signaling through L-selectin mediates enhanced chemotaxis of lymphocyte subsets to secondary lymphoid tissue chemokine.
    Subramanian H; Grailer JJ; Ohlrich KC; Rymaszewski AL; Loppnow JJ; Kodera M; Conway RM; Steeber DA
    J Immunol; 2012 Apr; 188(7):3223-36. PubMed ID: 22387549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.